Fleurir ABX LLC is a privately held specialty pharmaceutical company focused on developing anti-infective small molecule drugs to satisfy unmet medical needs. The company was formed in 2013 and is headquartered in Raleigh, NC (w/ offices in Philadelphia, NYC, and France). The corporate business model is predicated on specialization, management and scientific expertise, enhancing existing IP and partnering. Fleurir employs a flexible approach to accessing IP through partnering with other pharmaceutical companies or through acquisition of assets, particularly those currently undervalued or inadequately supported. Fleurir can enhance the value of NCEs through focused development led by Fleurir. The company also can enhance the value of marketed drugs.
| Website | http://fleurirabx.com |
| Revenue | $1 million |
| Employees | 3 (0 on RocketReach) |
| Address | 1234 HAMILTON ST, Philadelphia, Pennsylvania 19123, US |
| Phone | +1 919-889-1662 |
| Industry | Fine Art, Manufacturing General, Manufacturing |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Fleurirabx employee's phone or email?
Fleurirabx Questions
The Fleurirabx annual revenue was $1 million in 2026.
Fleurirabx is based in Philadelphia, Pennsylvania.
The NAICS codes for Fleurirabx are [32541, 325, 3254, 32].
The SIC codes for Fleurirabx are [28, 283].
